Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
or maybe this get revoked and toland goes to jail finally
Maybe we get FDA and CFO news all in one... WEEE WEEE WEEE
I can care less about what you think of Toland!!!! The guy is atleast busting his chops to dig us out of the ditch. You sound like the guy that sits in the car while his wife pushes it to to gas station when it runs out.
Get behind SGLN or you may as well burn $$$$$ on your grill...
ROCK ON TOLAND
they are not filing the required sec filings. they will be revoked. no one knows when
I was thinking the same thing, but not about him or SGLN...
SGLN will come around, they haven't been revoked yet, so I doubt it's comming.
no new "news" from the con man toland?
Hopefully this gets revoked soon so he shuts up
3 mil in volume today.
Now if the price would just go up...
@Lamb,
Hit ya back with the follow my fellow SGLN holder.. Our smoke signal will be when the old gang comes to save new investors lol..
BOOMMAGE
Holding strong and long on this stock.
Hit ya' smoove; hit me back.
By the time Toland mess around and hire a CFO and gets the overdue 10-Q's out folks will be rolling in $$$$$ that has held. Hopefully Toland pulls through for the loyal longs & others ..
May see a nice run before we get off the geys and get a true Quoted BID & ASK.. I think .025 would be a good start
Welcome Mr. Reed. I see why you are only followed by 10 people lol.. You are a very random person and I must say, what brings you to the Surgline board??
Must know something great is coming .... .0001 and no bid so nothing you can say or do to change that haha..
that strong feeling is just gas
Thanks for sharing your thoughts.
SGLN
@Climacus
Brilliant summation... I hope Toland does address a few of your questions in the upcoming PR. He seems to view the boad and address points when he is able too. I look forward to the next update and researching Sublingual Immunotherapy has really peaked my interest.
SGLN
Hello SGLN,
Having set aside some time a couple weeks ago to express concern, I felt it necessary to address the recent announcements from Surgline. I would like to point out that I am beginning to take a cautionary stance on information.
First and foremost, thank you, Toland, for addressing the topics of financials and a new CFO. I appreciate your willingness to inform shareholders and am very grateful.
Alright, we are going to be distributing a sublingual immunotherapy product. The manufacturer of the product is currently waiting on FDA approval for the packaging. Once the packaging has been approved (Which to my estimates should be announced in the coming days.), Surgline will be able to distribute the product.
If we are distributing the product, what distribution agreement do we have in place? Do we get exclusive rights to sales in North America? US? Or is there no exclusivity in our sales terrority? Can another company begin selling into our market? What are Surgline’s rights concerning the agreement? Is the manufacturer allowed to compete with our market?
I am of the opinion that Toland has high hopes for the product. If he is preparing to hire a CFO (And the company was interviewing on the last press release on 7/12/14.), then I surmise that only a couple of things could be happening or preparing to happen. The first option is that Surgline is already becoming self-sufficient by selling products in their catalog. This would justify his reasoning for hiring a new CFO. The second option is that Toland believes (And perhaps already has sales lined up) that he can sell the sublingual immunotherapy product in enough quantities to pay for filings and a new CFO. It is also possible that a combination of option one and two is happening, too. (Note: From the press release, it appears to be option two.)
There is little to argue if option one is occurring. This would be fantastic and show that our patience (Though sometimes stretched very thin) actually paid off. The boulder has begun rolling down hill and it won’t be much time before we create huge momentum.
More concerns come to light if it is option two. If Toland already has sales in line, then it may not be too bad. However, if sales are not already set up, what is the reasoning for hiring a CFO? I am not saying that Surgline doesn’t need a CFO, only that I am trying to figure out the justification for the hire if you are not 100% sure of the sales outcome.
I would like to assume that Toland would reason to the same outcome, but cannot be certain, so I simply state the questions that come to mind. I know that he cannot easily release the type of detail that could ease my mind. I can only hope that he isn’t the type of guy that goes by a handshake. (Gone are the days of trusting a man’s handshake. GET IT IN WRITING!) I believe in the company and think that if everything comes to fruition as stated in the last release, we will be moving much further forward in the coming months than we have in the last year. I look forward to seeing what occurs in the coming month.
Again, Toland, thank you for addressing these issues.
Sincerely,
C.
Agreed @Mexico10, Should hear something soon from Toland referencing FDA approval of packaging
I continue to hope/believe!!! Appreciate any DD that anyone comes across. I have a healthy amount of shares is the PPS does start to move.
SGLN
Uh, last I checked the board someone was getting together a class-action lawsuit against Surgline.. What happened to that??
Also when other stocks got halted and it was poven they lied a lawyer filed a suit against them. I do not recall ever seeing any law firm announcing anything against Surgline. WHY IS THAT??
Well IMO, SEC halted SGLN due to the past of the players involved with the merger. TOLAND has the most shares left and all the BIG DOGS have sold or only have a small position.
Hope it works out. Unfortunately, odds are against us. We will have to wait and see. After this last PR, if nothing happens, im pretty positive some will act look towards a lawsuit. Hope it works out...
Or somewhere near it lol.. "EVERY DOG HAS IT'S DAY". Feel like ours is near IMO
I hope you hit the nail on the head!
I have a strong feeling about SGLN and TOLAND pulling through for us "LONGS". If you have held since the day it was halted you are a WINNER IN MY BOOK. "Faith" is the only thing keeping this ticker alive, Faith in Toland, his vision and his direction.
I just feel so positive that our day when we see a quoted BID & ASK is coming by 2015. Strange feeling but I believe we see a stong uptrend as filings hit and revenue gets generated. **MEDPASSAGE** IMO, will play a huge roll in the success of SGLN and it shareholders will bank nicely.
@Chiselweed,
They must have moved on as SGLN continues to trade on the greys and not get REVOKED. We may here an update today on the FDA approval or early next week for the Packaging of our new Sublingual Immunotherapy. I am eager to see the product on our site and the possibility of getting revenues at a faster pace.
Look forward to hearing from Toland on any new updates. I am trrying to load a few more before things heat up here ..
hey who was that guy who claimed several months ago that this was finished,, done over> sooooo wrong,,, hmm who was that?
Sublingual Immunotherapy update should happen before months end per Toland's last update.
**I also wonder who advised Toland of such a market?? It seems like this has been happening behind the scenes for quite sometime, as things are moving along very fast. I'm thinking a company reached out to Toland and that is why we are entering another market. Either way we should get an update soon on FDA approval of packaging. Yes, "FDA" which means we are doing things the right way!!
GO SGLN
I like the plan that you have laid down. Hope that is the way it plays out? Would be one for the books, that's for sure!!
Go SGLN
Acer
FOLKS had plenty of chances to get out and will have even more with a QUOTED BID & ASK by years end. I believe in Toland and hope he makes good on bringing value to Loyal Longs.
Look forward to seeing more progress by the company and I enjoy reading the PRs on ihub. Heck at least he is still fighting unlike other companies that took the money and ran. As long as we been holding why sell with a new "CFO" on board??
Why sell when a 10-Q hits? Why sell when the Annual report hits?? Why sell when the Attorney Letter with Respect to current hits?? Why sell when the company is re-investing revenues to grow the company?? Why should I sell for CHEAP???
SGLN will be the "Ticker that could", watch how all the folks RUSH in above the BID to take a seat at OUR table. Do not give your seat up for cheap IMO.. .05+ will be here fast if Toland & a CFO gets the filings to get a live bid & ask... IMO, no R/S will happen either and Toland will do away with Toxic funding.
By year's end hopefully SGLN has a quoted BID & ASK.. How freaking awesome would that be for a so called "POS" to be halted for something that happened before Toland and we make the biggest run of all-time?? Investors have been left holding the "BAG" because the SEC decided to "halt" first and ask questions later..
Toland has a plan and I pray that the revenues start rolling i and the new "CFO" is dedicated to bringing true value here. The Original Gang holding SGLN will not sell anything under .03+ in my opinion. We can see a major move on the greysheets if the filings start to hit before reinstatement on OTC.. GO TOLAND.
I am pretty sure that the best thing that can happen to SGLN is for it to trade on the OTC again. The greysheets are not as exciting as the OTC tier Pro or Anti SGLN.
So if you are really trying to save people you will wish the same, unless you have other motives. SGLN looking to generate revenues and get off the grey market is a great thing for all of us.
I will be adding when I can so that once we do trade on OTC again I can say Weeeeee, All the way to the bank haha!!!
and yet again no mention of the required filings you scam artist scumbag douche!
stop pretending you are running a company you fraud!
SGLN baby.. it is the year of THE BULL haha. Looking to add a few more at .0001.. Are there shares still available?? Toland has been awesome with inforing us here on ihub about PR's and company updates. We wanted info on Filings, fins & etc.. He delivered in his last post. "IN SEARCH FOR A QUALIFIED CFO"... Heck basic lotto play IMO and if they get current and off the greys the PPS will be a lot higher than .0001.
Getting off the greys means the company is making $$$$$ and profitable. Hopefully the CFO will work for a few preferred shares and being part of a growing vibrant company!!
S
G
L
N
BOOM
Hell froze over?LOL---GLTY-3
What's he really going to say?
Hey, people I F'ed up.
I didn't know what I was doing.
I trusted the wrong people.
What could he say to make the shareholders feel better.
I believe actions speak louder than words. He's apparently still here trying, while others left.
That's what he's saying to shareholders.
He's here, he's trying, be patient.
We all had high hopes for this. We're not real sure what they did to get it suspended. All I can say is I'm glad Toland is still trying to keep the ole girl alive. I've seen other stocks that got suspended, and they basically quit. No updates, no attempts to keep it going, nothing.
The whole situation is crap and probably could have been avoided, but at least he stuck around and looks to be trying.
Who knows maybe this will be the one to come back. Then what will we all say?
Good Luck to SGLN and all of us.
Come clean to us Tom,you'll feel better.I promise.
I agree in the fact that this,in the beginning,had an excellent business model.What's happened since has been text book "what NOT to do if you are a CEO".
What a shame,this had sooooo much potential.
I really feel bad for the people who lost A LOT of money on this POS.
Toland should man up and come clean.
GLE-3
A new CFO?
Would be one of the most important actions.
We cannot value SurgLine at all without any financials, nor can the market.
Market says we are worth 0.0001.
Not very encouraging at the moment.
Nw12
@CallMeBull "ye of little FAITH" I am not banking on things lining up for SGLN in days. As long as TOM continues to work, why not back him and hold onto my shares??? The value of my shares can only increase at this point. Thomas Toland had a vision, however, the SEC came in and halted first and asked questions later. LOTS OF SHARES hit the market due to such Toxic funding and money hungry people causing Toland to start over.
Toland is putting every ounce of his time into this company so I can at least hold my darn shares until he rights the ship. Heck, I am not sure what is keeping the man going but he clearly has a vision and will fight until his last breath to get some value for his common holders.
BILLIONS OF SHARES WERE SOLD yet he sold none. The SEC should be the one apologizing and repaying TOM for the money he has lost to stay a float. IMO, someone is standing behind TOM in the shadows and feels his business plan will be a force to reckon with. SCAM FONGED OR DUPED call it what you want but I will gladly buy more shares and lock them away. IF, a CFO, likes what they see and $$$$$ starts flowing going "CURRENT" will be a REALITY IMO.. The road Toland has to take to right the ship is one not many CEO's let alone a human is willing to take.
SGLN- Long & Stronger than ever
Sadly, it seems as if the only way we get a CFO is if this "product launch" is successful and brings in cash for Tolland to pay for one... So therefore I think it's time to put this one away again
Nice try tom
Hey Tom, keep up the good fight. We are behind you all the way. Have a great summer.
Well, Well, Tom interviewing for an in-house CFO to become current.. Wow, wishing Surgline the best in its new revenue generating endeavor and hope to here more over the next 3 months. Let's END the year on a positive note Tom SGLN rock it!!!
Sounds promising. Let's make it happen!
Thank you for the update Tom. Thank you for not giving up on Surgline and the good things it has to offer. And most of all, thanks for the hard work you are putting into getting the ball rolling!
For Immediate Release For Further Information Contact:
July 12, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE on business and filing status
WEST PALM BEACH, Fla., July 12, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. is waiting for the manufacturer of its Sublingual Immunotherapy product to receive its final approval of labeling requirements from the FDA and anticipates that the approval will be forthcoming within approximately the next 14 days.
The Company will launch its sales efforts immediately following the approval process to its target market and will commence recruiting and training a sales force to penetrate the primary care marketplace.
These new revenues are anticipated to allow the company to generate new cash flow opportunities while pursuing its cost savings model for savings to surgery centers and hospitals. The Company estimates that the SLIT allergy market in the U.S. to be in excess of 1 billion dollars per year.
The Company is also in the process of interviewing potential candidates to act as its in-house CFO in anticipation of its impending launch of the Allergy program and other impending program opportunities. The candidate will have prior public company reporting experience.
Once the Company successfully recruits its new CFO candidate, it plans to use the proceeds from the Physician Allergy program to become current with its past due filings and reporting at the soonest opportunity.
The Company will continue to provide updates on material developments on both its Allergy program as well as its reporting status over the next 45 to 60 days.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Very well said. Have missed your posts! I have the exact same feelings, and i thank you for putting in words what i could not.
Mr. Toland, it is time to bring us up to speed on all. If there is no hope, please let us know. If there is, please fill us in, but on all aspects of the company.
SGLN
Acer
I have lost faith in this company, I am a bag holder. ..shame on me
Very well said. I imagine, even though not descriptive, my post bleeds frustration. I still hope, but my candle is almost out of wick.
Good Afternoon SGLNer's,
It’s been quite some time since my last post. I wanted to write and express my views on Surgline.
Firstly, about a month ago, I wrote Toland. The reason for my correspondence was to ask for him to put out a PR letting us know the status of the company. Toland said it was a good idea, but never submitted a press release. After about two weeks, I sent another email with the same request. He shot out a PR by mid-morning. It was great to see a press release after so long, but definitely not the substance I was requesting. The main topic of my request was for the company to address the elephant in the room. (Or more properly put, the multiple elephants in the room.) I was asking for an update on the status of the financials, on-going operations and any other pertinent information. Sadly, this was not released, though I was appreciative for the release.
For quite some time, I have been a strong advocate for Surgline. I genuinely believe in the business model and think with perseverance, Surgline could prosper. With the current status (or lack thereof) of the company, I am placed in a bit of a paradox. Believing in a company and/or an individual is okay. And in most circumstances shows the believer to be a logical, well-rounded individual. However, issues arise when the believer is no longer asked to have faith, but to have blind faith. I am of the opinion that Surgline (whether inadvertently or blatantly is irrelevant) asked their shareholders to have blind faith approximately 22 months ago when they were placed on a suspension and subsequently regulated to the grey market. They did this because they had no other option and couldn’t inform shareholders due to a list of reasons. And even though they asked us to have blind faith, we, as long term shareholders, stuck with Toland. We even defended him (Not that he asked us to) against the onslaught of verbal attacks that were produced daily.
And now…here we are….almost two years since the halt with only droplets of information trickling down to us. How are we supposed to feel? It was told and touted that Surgline was interested in long term shareholder value. What constitutes a long term shareholder? IRS tax code states a long term shareholder as an individual that has held the stock for over one year. I am sure that the majority of people watching the board today would be considered long term shareholders as per IRS code. What guidelines does Surgline use to classify a short term holder versus long term holder? (Rhetorical)
I believe that Toland is just as upset as shareholders about the obstacles Surgline has faced and continues to endure. However, Toland is at the helm of the ship. He is required to overcome and prosper. I know…being captain sucks! He has contributed in this effort by not taking a salary. (Note: I honestly have no idea if Toland is not taking a salary anymore. Since we have no documentation to follow, I must go by past knowledge.) He continues to work and at the very least, informs shareholders with the rare PR letting us know that they are still kicking.
The excitement that once ruled my thoughts on Surgline has been dissipating over the course of the last year. My understanding about the obstacles faced and attacks endured cannot be made to last forever. Compassion is the cornerstone to a well-rounded individual. At a certain point, I no longer feel compassionate, but start to feel ignorant. Was I being ignorant for believing? (Rhetorical)
I am at a loss for words. I want to say I don’t believe, but I still do. I am not angry, but simply frustrated. (I have a feeling anger will be coming after the frustration subsides.) I am absolutely fed up with being out of the loop. It’s time we were properly informed. If I had a recommendation for Toland, it would be to hold a conference call updating shareholders and allowing for questions. I certainly don’t want to speak for the group, but I still believe in the company and think others do too. That said, my ‘belief” oil reserves are running extremely low. You need to fill the reserves back up, Toland. Hook me up!!!!!
SGLN
I want SGLN to either move forward ( preferable) or revoked the damn thing already. I'm really tried of the limbo thing. I've been a believer the past few years, but....
Followers
|
270
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
72077
|
Created
|
04/29/05
|
Type
|
Free
|
Moderators |
SurgLine International, Inc., a premiere reseller and distributor of FDA approved stable technology for surgical implants and surgical instruments in the operating room, has executed a seller participation agreement on March 20, 2013 with MedPassage Inc. (medpassage.com) as a charter member of the MedPassage ecosystem. The Company will offer its full line of products that it sells to ambulatory surgery centers and hospitals through its affiliation with MedPassage at tremendous savings.
"The MedPassage ecosystem empowers medical centers and device companies to collaborate and exchange products more efficiently than ever before", said Tom Toland, CEO of SurgLine International, Inc. "We are pleased to work alongside MedPassage and their talented executive management team and are anticipating a tremendous opportunity for SurgLine and its product offering."
Over the coming weeks and months, SurgLine and MedPassage will work closely to load its catalogs of FDA approved cost-effective surgical products onto the MedPassage ecosystem for sale to surgery centers, hospitals, Accountable Care Organizations and Physician Owned Distributors also known as POD's.
At SurgLine, we believe that the ability to level the playing field for both buyers and sellers of medical devices and medical and surgical products will be the way of the future, and SurgLine will be right there leading the way with MedPassage.com.
About SurgLine, Inc.
SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self-insured employers and insurance companies.
About SurgLine International, Inc.
SurgLine International, Inc. is a holding company that, in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc.
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
For Further Information Contact:
Thomas Toland
949-698-8485
![]() "More Value for your healthcare dollar." SURGLINE ALSO FORECAST'S OVER $10,000,000 IN REVENUES! China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine, Inc. ("SurgLine") and one of its previously announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the final stages of completing a multi-million dollar order and as a result has revised its forecast to be in excess of $10 million by the end of 2012. Additionally, the Company is negotiating with other stocking distributors and channel sales agreements with third parties regarding additional sales and distribution of the Company's product line.
For ALL SEC Filings: Interwest Transfer Company, Inc., http://sec.gov/cgi-bin/browse-edgar?company=&CIK=0001126411&action=getcompany
*1. THE 19.1% PARTNERSHIP WITH MD CAPITAL ADVISORS **2. THE 19.1% PARTNERSHIP WITH CORE WINNER HOLDINGS OWNED BY ERIC SIU...A GIANT IN THE MEDICAL PRODUCT INDUSTRY We will be obtaining products through a sourcing and manufacturing relationship with Core Winner Holdings, LTD. ("Core winner"). Core Winner, based out of China, and holds approximately 19.1% of our common stock. The beneficial owner of Core Winner is Eric Siu. FOLLOW THE DD... Eric Siu graduated with honors from London University, UCL, Mathematics. He has over twenty years of management experience in in high-growth, international medical businesses. His experience includes medical product procurement and healthcare supply chain operations in China, medical product manufacturing in Germany and China, medical product distribution in the US. Eric is a health care thought leader in China. He was instrumental in introducing MIS (minimally invasive surgery) best practices into the PRC, and sold China's first laparscope tower to China's leadership healthcare unit, PLA Hospital 301. Eric also organized over 200 CME programs in conjunction with the Chinese Ministry of Health and international medical device manufacturers for Chinese surgeons. He is a medical consultant and director of two leading hospitals in China, and in 2009, one of Eric's companies was voted 7th most trusted medical company in China and one of the top 20 medical brands in China*. Eric's medical optics manufacturing company is one of the world's leading manufacturers of specialty surgical optics, and he has an exclusive partnership agreement with the world's largest radiotherapy company, Varian Medical Systems, to market its Proton System in China. Eric also has extensive technology, operations and product development with German-based companies. Eric's German company works with over 100 medical manufacturing customers ERIC ALSO OWNS A COMPANY CALLED ASIA WEST CAPITAL PARTNERS WHO JUST ON AUG 19TH SIGNED A STRATEGIC ALLIANCE WITH OUR OTHER 19.1% PARTNER MD CAPITAL ADVISORS. ![]()
VA HOSITAL! Surg offers an entire portfolio of leading and innovative products that address every indication. Surg products leverage proven designs and are packaged as universal and all-in-one solutions - all available from one company. All Surg products are FDA approved and are manufactured in ISO certified facilities. Where required by the FDA, products are manufactured in FDA certified facilities. SurgLine currently offers the following products:
ENDOSCOPE PRODUCTS:
MEDICAL DISPOSABLES:
MORE ON SURGLINE! About SurgLine, Inc. SurgLine (www.surgline.com) sources and distributes high quality medical products at discount prices, thereby reducing the historical brand premium paid by healthcare providers. SurgLine offers medical and surgical supplies and products at substantial savings through stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup. SurgLine's management team is well-respected and experienced in the healthcare industry. At SurgLine our mission is to sell the highest quality surgical products at the lowest possible cost…period. Our signature product line, Surg, is produced by the same manufacturers as other leading medical companies without the brand premium. We are reducing the 'brand premium' much in the same way as Costco has with their Kirkland brand. By removing the brand premium we can pass along cost savings to our customers which include U.S. based distributors and institutions. SurgLine is founded on the premise that the U.S. healthcare system MUST reduce spending and do more with less, thus Surgline offers it's exclusive line of high quality "private labeled" surgical products, under our brand "Surg," for the operating and emergency room at substantial savings of up to 40% when compared to the larger well known legacy medical and surgical suppliers. SurgLine business model focuses on procuring the "Best of Class" products and then distributing these products to hospitals and free standing surgery centers throughout the United States for substantially less money. SURGLINE PRODUCTS! SurgLine has over 20,000 SKUs of FDA approved products. SurgLine's signature product line, Surg, is the value leader and designed to be of equal or better quality than national brands. SurgLine, Inc. offers "more value for less of your healthcare dollar" when compared to the competition. Benefits afforded to our clients who partner with SurgLine include: > Highest quality products for operating rooms, emergency departments and trauma units. Mr. Toland has more than 30 years of healthcare management experience. Mr. Toland started his healthcare career with American Medical International, followed by financial management and corporate business development positions with Summit Health Ltd., OrNda HealthCorp, and Tenet Healthcare and two large not for profit hospital systems located in Southern California. Mr. Toland is a graduate of the University of Southern California with a major in Accounting in 1980. Richard Dutch | President & COO... Mr. Dutch has over 24 years of healthcare industry experience. Mr. Dutch previously was a Corporate Business Manager with the 3M company, for 17 years, responsible for the P/L, growth and management of the west regions Acute Care and Surgery Center business. Most recently, Mr. Dutch was the President at Sterling Medical Products, a national orthopedic distribution company. His areas of expertise are complex healthcare systems, GPO's, new product launches, navigating the challenging Government market, P/L, and client relationships. Mr. Dutch holds an MBA degree, as well as, a BS degree in Health & Medical Science, Six Sigma certification and was instrumental for the launches of three successful start-up companies.
Barry Hollander | Chief Financial Officer... Mr. Hollander has vast public company experience and is currently the CFO of China Nuvo since 2002 and Techs Loanstar, Inc. since February 2010. Mr. Hollander has held various accounting, senior management and executive financial positions. From 1994 to 1999, Mr. Hollander was the CFO of California Pro Sports, Inc., an in-line skate importer, marketer and distributor. Mr. Hollander has a BS degree from Fairleigh Dickinson University. MORE HUGE NEWS: 09/17/2012 |
Charts
_____________________________________________________________________________________________________________________________
CHARTS FOR YOU TECHNICAL PLAYERS!
( 1 month daily, 3 month daily, 1 year weekly)
(3 month daily)
(6 Month Daily w/ ADX,..................................... 6 Month w/ Psar & PPO)
( 1 yr daily , .................................................... 1 yr daily )
1 YR Weekly ,........2 YR Daily
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |